Back to results
US 2022/0183339 A1Published application
Acetylcholinesterase inhibitor
AssigneeTaiko Pharmaceutical Co., Ltd.
InventorsNorio Ogata, Hideaki Tagishi
Life of this patent
Estimating the term…
Abstract
The object of the present invention is to search for and to provide a novel acetylcholinesterase inhibitor. An acetylcholinesterase inhibitor comprising wood creosote as the active ingredient is provided.
Claims21
A pharmaceutical composition for inhibiting acetylcholinesterase or a food composition for inhibiting acetylcholinesterase comprising wood creosote as the active ingredient.
(canceled)
A therapeutic method or a method for suppression of progression of a disease or a condition related to a decline in acetylcholine activity in a subject comprising:
- a step of applying an effective amount of wood creosote to said subject.
Dependencies are inferred from the claim text.